Funded Tech Companies
Mogrify
Mogrify is a leading biopharmaceutical company, based in Cambridge, England. Financial backing was provided by Astellas Venture Capital, Trend Investment Group and ParkWalk Advisors.
Company Overview
Company Name
Mogrify
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Bio-Innovation Centre 25 Cambridge Science Park, Milton R
Cambridge, England, CB4 0FW
UK
Cambridge, England, CB4 0FW
UK
Phone
Website
Email Address
Company Background Information
Overview
Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and growth factors required to produce any target human cell type from any source human cell type.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/2/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Darrin Disley
Chief Operating Officer
Joe Foster
Company Investors
- Astellas Venture Capital
- Trend Investment Group
- ParkWalk Advisors
- Ahren Innovation Capital
- Private Investors (Jonathan Milner)
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs